Clinical trials are the next step for testing vaccine against Alzheimer’s-promoting tau protein

University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau—a protein in the brain associated with Alzheimer’s dementia.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup